(Q41444552)

30 September 2017

1 reference

title

Chemo-embolization in the treatment of liver metastases from colorectal cancer (English)

1 reference

30 September 2017

1 reference

Cascinu S

1

1 reference

PubMed ID

9118121

30 September 2017

Wadler S

series ordinal

2

1 reference

30 September 2017

1 September 1996

1 reference

30 September 2017

Cancer Treatment Reviews

1 reference

30 September 2017

22

1 reference

30 September 2017

5

1 reference

30 September 2017

355-363

1 reference

30 September 2017

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Regional chemotherapy of neoplastic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Regional chemotherapy of colorectal cancer metastatic to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Experimental studies on the circulatory dynamics of intrahepatic tumor blood supply

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Evaluation of hepatic dearterialization in primary and secondary cancer of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Hepatic arterial redistribution for intraarterial infusion of hepatic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Arteriographic demonstration of collateral arterial supply to the liver after hepatic artery ligation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Repeated arterial embolization of rat livers by degradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Studies in Pharmacokinetics and Tolerance of Substances Temporarily Retained in the Liver by Microsphere Embolization

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Improved regional selectivity of hepatic arterial BCNU with degradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Regional Distribution of Diffusible Tracers and Carbonized Microspheres in the Left Ventricle of Isolated Dog Hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Starch microsphere-induced arterial flow redistribution after occlusion of replaced hepatic arteries in patients with liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Changes in vascularity of liver tumours after hepatic arterial embolization with degradable starch microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Hepatic Artery Ligation and Cytotoxic Infusion in Treatment of Liver Metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Hepatic artery ligation and 5-fluorouracil infusion for metastatic colon carcinoma and primary hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Transient hepatic dearterialization followed by regional intra-arterial 5-fluorouracil infusion as treatment for liver tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Effective retreatment of patients with colorectal cancer and liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Indications and therapeutic possibilities using degradable microspheres in liver malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Regional chemotherapy for colorectal liver metastases: a phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Treatment of patients with irresectable liver metastases from colorectal cancer by chemo-occlusion with degradable starch microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: post-treatment management and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

Chemoembolization for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990008-0

7 January 2021

10.1016/S0305-7372(96)90008-0

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

9118121